Cite
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies
MLA
Antonio Carotenuto, et al. “Update on Infective Complications in Patients Treated with Alemtuzumab for Multiple Sclerosis: Review and Meta-Analysis of Real-World and Randomized Studies.” Expert Opinion on Drug Safety, vol. 20, no. 10, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4fb173d6bcfe3a8054cb2a0ec385995c&authtype=sso&custid=ns315887.
APA
Antonio Carotenuto, Cinzia Valeria Russo, Emanuela Zappulo, Marcello Moccia, Giulio Viceconte, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, & Ivan Gentile. (2021). Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies. Expert Opinion on Drug Safety, 20(10).
Chicago
Antonio Carotenuto, Cinzia Valeria Russo, Emanuela Zappulo, Marcello Moccia, Giulio Viceconte, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, and Ivan Gentile. 2021. “Update on Infective Complications in Patients Treated with Alemtuzumab for Multiple Sclerosis: Review and Meta-Analysis of Real-World and Randomized Studies.” Expert Opinion on Drug Safety 20 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4fb173d6bcfe3a8054cb2a0ec385995c&authtype=sso&custid=ns315887.